1. A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement. (November 2019) Authors: Bell Gorrod, Helen; Kearns, Ben; Stevens, John; Thokala, Praveen; Labeit, Alexander; Latimer, Nicholas; Tyas, David; Sowdani, Ahmed Journal: Medical decision making Issue: Volume 39:Number 8(2019) Page Start: 899 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma. (3rd June 2019) Authors: Gibson, Edward J.; Begum, Najida; Koblbauer, Ian; Dranitsaris, George; Liew, Danny; McEwan, Phil; Yuan, Yong; Juarez-Garcia, Ariadna; Tyas, David; Pritchard, Clive Journal: Journal of medical economics Issue: Volume 22:Number 6(2019) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early Access to Medicines Scheme: real-world data collection. Issue 12 (December 2019) Authors: Pang, Hok; Wang, Meng; Kiff, Christopher; Soni, Mira; Stein, Dara; Tyas, David Journal: Drug discovery today Issue: Volume 24:Issue 12(2019) Page Start: 2231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗